03Jun 2022
The Norwich trabeculectomy study: risk factor analysis for the development of adverse, thin cystic blebs

The Norwich trabeculectomy study: risk factor analysis for the development of adverse, thin cystic blebs

To investigate potential risk factors, particularly antimetabolite choice, about the development of adverse bleb morphology in eyes that had undergone trabeculectomy surgery. Modern use of mitomycin‐C appeared to be better than 5‐fluorouracil as an adjunctive antimetabolite used at the time of trabeculectomy, with respect to the development of preferable final bleb morphology. The only potential preoperative risk factors that were significant with respect to adverse cystic bleb development were care in the private health sector and previous ocular surgery involving a conjunctival incision.

  • #ophthalmology

Like

Save

Share